Effect of priming on the immunomodulatory response of mesenchymal stem cells (adMSC) with immunogenic synthetic peptides from Leishmania braziliensis.
Palabras clave:
Mesenchymal stem cells, immunomodulatory potential, immunogenic peptidesResumen
Leishmaniasis is a zoonotic disease that causes major public health problems, mainly in tropical or subtropical countries,
causing approximately 70,000 deaths per year and currently there is no approved vaccine. Therefore, research into the
development of effective therapies that help both the elimination of the parasite and the aesthetic recovery of wounds, through
the search for synthetic antigenic systems with immunogenic activity, is nowadays a necessity. Recently, the
immunotherapeutic potential of human mesenchymal stem cells (hMSCs) and the secretome and exocytic vesicles they
produce when cultured in specific media have been described [1]. It has also been described that they have regenerative and
antimicrobial potential and that these effects are enhanced when stimulated with different antigens. The present study aimed
to characterize the secretome of hMSCs, treated with synthetic immunogenic peptides from Leishmania braziliensis, and to
evaluate their immunomodulatory potential. Adipose tissue-derived hMSCs, which were characterized according to
international standards [2], were used. For this work, cells at passage eight were exposed to two synthetic immunogenic
peptides MSD1 and CBP, designed in silico, from L. braziliensis and lipopolysaccharide (LPS) as a positive control. The
secretome was collected at 48 and 96h and characterized firstly by measuring the expression of Interleukin 6 (IL-6) by an
ELISA method and the expression of cytokines and other proteins using an 80- antibodies targets in a chemiluminescence
panel. The results have shown a proinflammatory profile at the level of cytokine expression for the treatments with MSD1, CPB
and LPS [3,4]. These were characterized by an increase in the expression of proinflammatory cytokines such as INF-γ, IL-6,
IL-16, TNF-α and TNF-β. In summary, the secretome of adipose tissue hMSC pre-treated with synthetic immunogenic
peptides from L. braziliensis presents differences in the level of cytokine expression with a tendency towards a
proinflammatory profile.
Descargas
Citas
Sanchez-Castro, E. et al. (2021) Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming. Front Immunol. 11:609961. doi: 10.3389/fimmu.2020.609961.
Viswanathan, S. et al. (2019). Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy, 21(10), 1019–1024. doi:10.1016/j.jcyt.2019.08.002
Archivos adicionales
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.